Leishmaniasis: een tropische ziekte

Wijburg HC, Wieringen PMV van, Zee CLM van der. Een zuigeling met vijf weken febris e causa ignota en een redelijk goede klinische conditie; leishmaniasis. Ned Tijdschr Geneeskd 1990;134:1409-12.

Ortega-Barria E. Leishmnia species (leishmaniasis). In: Priciples and practice of pediatric infectious diseases, New York: Churchill Livingstone, 1997: 1394-403.

Minodier P, Piarroux R, Garnier JM, et al. Pediatric visceral leishmaniasis in southern France. Pediatr Infect Dis J 1998;17:701-4.

Pearson RD, Sousa A de Q. Clinical spectrum of leishmaniasis. Clin Infect Dis 1996;22:1-13.

Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.

Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. New Eng J Med 1999;340:764-71.

Meyerhoff A. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999,28;42-8.

Sundar S, Agrawal NK, Sinha, PR, et al. Short-course low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann Intern Med 1997;127:133-7.

Catania S, Aiassa C, Tzahtzoglou S, et al. Visceral leishmaniasis treated with liposomal amphotericin B. Pediatr Infect Dis J 1999;18:73-9.